Table 2. . Summary on the analytical performance of published plasma paracetamol LC–MS/MS quantitation methods.
Year of study | Method description | Sample volume (μl) | LLOQ (mg/l) | LC run-time (min) | Linearity (mg/l) | %CV (exclude LLOQ) | Ref. | |
---|---|---|---|---|---|---|---|---|
Intra-assay | Interassay | |||||||
2017 | Protein precipitation | 20 | 0.125 | 5.5 | 0.125–50 | <1.0 | <1.4 | Current study |
2015 | Protein precipitation, vacuum drying and reconstitution | 10 | 0.05 | 20 | 0.05–50 | <7.1% | <7.2% | [26] |
2013 | Protein precipitation | 50 | 0.003 | 4.2 | 0.003–20 | <4.9 | <8.7 | [23] |
2013 | Protein precipitation, vacuum drying and reconstitution | 25 | 0.25 | 10 | 0.25–20 | <2.9 | <6.3% | [25] |
2012 | Protein precipitation, vacuum drying and reconstitution | 50 | 0.020 | 18 | 0.02–10 | <3.9%† | [24] | |
2011 | Protein precipitation | 100 | 0.03 | NA | 0.03–9 | <8.4%† | [43] | |
2010 | Protein precipitation | 50 | 0.01 | 6 | 0.01–5 | <6.8 | <10.0 | [28] |
2008 | Protein precipitation | 50 | 0.012 | 6 | 0.012–25 | <10.8 | <13.0 | [44] |
2006 | Protein precipitation, followed by SPE | 100 | 5 | 70 | 5–100 | <5.7 | <6.3 | [45] |
2003 | Protein precipitation | NA | 0.01 | 25 | 0.01–5 | <3.4%† | [46] |
†Not specified.
LLOQ: Lower limit of quantitation; NA: Not available.